Global Herbal Medicine Market Research Report -
 Forecast To 2023

Global Herbal Medicine Market Research Report - Forecast To 2023

ID: MRFR/HC/2358-HCRR | August, 2018 | Region: Global | 80 pages | Half-Cooked Research Reports

Global Herbal Medicine Market Information; By System (Ayurveda, Chinese, Western and Other), Application (Pharmaceutical, Personal Care and Other), By Source (Vegetable (Leaves and Fruit, Seeds, Roots, Bark and Other) and Animal (Oils, Bones, and Other)) - Forecast to 2023


Market Synopsis of Global Herbal Medicine Market:
Market Scenario:
Herbal medicine, or phytomedicine is a medicinal system using a plant or animal materials such as seeds, roots, leaves, bark, flowers, oils etc. for medicinal purposes. Herbalism has emerged from a long historical tradition of using nature for curing diseases. According to WHO estimates, almost 80% of population of many Asian and African countries depend on traditional medicine for primary health care. The market drivers for the global herbal medicine market are growing aging population, increasing consumer awareness, little or no side effects, supplier innovations, and the release of Current Good Manufacturing Practices (CGMP) for dietary supplements by the FDA. Another factor is escalating prices, tighter health budgets of modern medicinal system which has driven consumers towards the more economical and safer herbal medicine systems. The market constraints are lack of research and standardization in herbal medicines, poor legal and regulatory frame work which causes patent problems, poor manufactured herbal products etc. Considering all these factors the market for herbal medicine is expected to reach $ 111 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 7.2 % during 2017-2023.
Research Methodology


Research methodology Herbal Medicine Market
Intended Audience
Global herbal medicine providers, manufacturers & suppliers
Research and development (R&D) companies
Market research and consulting service providers
Academic institutes and universities
Key Players of Global Herbal medicine Market:
Key players profiled in the report are Himalaya Drug Company, Blackmores, Tsumura, Schwabe, Madaus, Arkopharma, Sheng Chang Pharmaceutical Company, China Herbs Company, Nutraceutical International Corporation, Ricola AG, Zandu Pharmaceutical Works Ltd, Hamdard laboratories, Dabur, Patanjali Ayurved Ltd.

Figure 1 Global Herbal Medicine Market by Therapeutic Application, 2016 (% Market Share)

Herbal Medicine Market by Therapeutic Application


Herbal Medicine Market Segments:


The global herbal medicine market is segmented on the basis of system. Based on the system, the market has been segmented as Ayurveda, Chinese, Western and other. Based on the application, the market has been segmented as pharmaceutical, personal care and other. Based on the source, the market has been segmented as vegetable and animal. The vegetable segment is sub segmented into leaves and fruit, seeds, roots, bark and other. The animal segment is sub segmented into oils, bones, and other.


Herbal Medicine Market Regional Analysis


Asia Pacific countries such as China followed by India accounts for the maximum market share due to its tradition of using the herbal system. Europe is the second largest market due to large disposable income and growing demand for natural therapies and remedies. The European market will be led by France followed by Germany. Asia pacific region will be the fastest region because of which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.
The report for Global Herbal medicine Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Table of Contents



1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5 GLOBAL HERBAL MEDICINE MARKET, BY SYSTEM

5.1 AYURVEDA

5.2 CHINESE

5.3 WESTERN

5.4 OTHER

6 GLOBAL HERBAL MEDICINE MARKET, BY APPLICATION

6.1 PHARMACEUTICAL

6.2 PERSONAL CARE

6.3 OTHER

7 GLOBAL HERBAL MEDICINE MARKET, BY SOURCE

7.1 VEGETABLE

7.1.1 LEAVES AND FRUIT

7.1.2 SEEDS

7.1.3 ROOTS

7.1.4 BARK

7.1.5 OTHER

7.2 ANIMAL

7.2.1 OILS

7.2.2 BONES

7.2.3 OTHER

8. GLOBAL HERBAL MEDICINE MARKET, BY REGION

8.1 NORTH AMERICA

8.1.1 INTRODUCTION

8.2 EUROPE

8.2.1 INTRODUCTION

8.3 ASIA-PACIFIC

8.3.1 INTRODUCTION

8.4 MIDDLE EAST & AFRICA

8.4.1 INTRODUCTION

9. COMPETITIVE LANDSCAPE

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

9.1.1 STRATEGIC PARTNERSHIP

9.1.2 MERGER & ACQUISITION

10 COMPANY PROFILE

10.1 HIMALAYA DRUG COMPANY

10.1.1 OVERVIEW

10.1.2 PRODUCT OVERVIEW

10.1.3 FINANCIALS

10.1.4 KEY DEVELOPMENTS

10.2 BLACKMORES

10.2.1 OVERVIEW

10.2.2 PRODUCT OVERVIEW

10.2.3 FINANCIALS

10.2.4 KEY DEVELOPMENTS

10.3 TSUMURA

10.3.1 OVERVIEW

10.3.2 PRODUCT OVERVIEW

10.3.3 FINANCIALS

10.3.4 KEY DEVELOPMENT

10.4 SCHWABE

10.4.1 OVERVIEW

10.4.2 PRODUCT OVERVIEW

10.4.3 FINANCIALS

10.4.4 KEY DEVELOPMENTS

10.5 MADAUS

10.5.1 OVERVIEW

10.5.2 PRODUCT OVERVIEW

10.5.3 FINANCIALS

10.5.4 KEY DEVELOPMENTS

10.6 ARKOPHARMA

10.6.1 OVERVIEW

10.6.2 PRODUCT OVERVIEW

10.6.3 FINANCIALS

10.6.4 KEY DEVELOPMENTS

10.7 SHENG CHANG PHARMACEUTICAL COMPANY

10.7.1 OVERVIEW

10.7.2 PRODUCT OVERVIEW

10.7.3 FINANCIALS

10.7.4 KEY DEVELOPMENTS

10.8 CHINA HERBS COMPANY

10.8.1 OVERVIEW

10.8.2 PRODUCT OVERVIEW

10.8.3 FINANCIALS

10.8.4 KEY DEVELOPMENTS

10.9 NUTRACEUTICAL INTERNATIONAL CORPORATION

10.9.1 OVERVIEW

10.9.2 PRODUCT OVERVIEW

10.9.3 FINANCIALS

10.9.4 KEY DEVELOPMENTS

10.10 RICOLA AG

10.10.1 OVERVIEW

10.10.2 PRODUCT OVERVIEW

10.10.3 FINANCIALS

10.10.4 KEY DEVELOPMENTS

10.11 ZANDU PHARMACEUTICAL WORKS LTD

10.11.1 OVERVIEW

10.11.2 PRODUCT OVERVIEW

10.11.3 FINANCIALS

10.11.4 KEY DEVELOPMENTS

10.12 HAMDARD LABORATORIES

10.12.1 OVERVIEW

10.12.2 PRODUCT OVERVIEW

10.12.3 FINANCIALS

10.12.4 KEY DEVELOPMENTS

10.13 DABUR

10.13.1 OVERVIEW

10.13.2 PRODUCT OVERVIEW

10.13.3 FINANCIALS

10.13.4 KEY DEVELOPMENTS

10.14 PATANJALI AYURVED LTD.

10.14.1 OVERVIEW

10.14.2 PRODUCT OVERVIEW

10.14.3 FINANCIALS

10.14.4 KEY DEVELOPMENTS

10.15 OTHERS

11 CONCLUSION

11.1 KEY FINDINGS

11.1.1 FROM CEO’S VIEWPOINT

11.1.2 UNMET NEEDS OF THE MARKET

11.2 KEY COMPANIES TO WATCH

11.3 PREDICTION OF HERBAL MEDICINE INDUSTRY

12 APPENDIX